Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04080505Phase 3Terminated
A Phase 3 trial of Potassium iodide in Graves' disease, sponsored by Columbia University. Started Feb 2015; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04080505.